The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.

Elon Musk's Neuralink has achieved a milestone with the FDA's "breakthrough device" designation for its vision implant, Blindsight.

Elon Musk's brain-chip company Neuralink has received the FDA’s "breakthrough device" designation for its experimental vision-restoring implant, Blindsight.

Blindsight, the experimental vision-restoring implant by Elon Musk’s brain-chip startup, Neuralink, has received the U.S. Food and Drug Administration’s (FDA) "breakthrough device" designation, according to the company.

Neuralink has proven its electronics to brain connection device and now has FDA approval for a Blindsight device.

With Blindsight now receiving the FDA’s Breakthrough Device Designation, Neuralink looks set to push forward with technology to help those with vision disabilities as well. Stay tuned as we continue to follow this story for further updates.

Elon Musk 's brain-chip start-up, Neuralink, has secured approval from the US Food and Drug Administration (FDA) for an experimental implant device known as 'Blindsight.' This groundbreaking technology aims to restore vision in individuals who have lost both eyes and their optic nerve,

Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation. The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions.

Elon Musk’s Neuralink has recently achieved a significant milestone with its experimental vision-restoring implant, Blindsight. The U.S. Food and Drug Administration (FDA) has granted the device a "Breakthrough Device" designation,